Short-term clinical efficacy of the association betamethasone 17-valerate 21-acetate + tretinoine + salicylic acid in outpatients affected with disseminated keratotic plaque psoriasis: A double blinded placebo-controlled multicentric randomized clinical trial;Efficacia clinica a breve termine dell'associazione betametasone 17-valerato 21-acetato + tretinoina + ac. salicilico in pazienti affetti da psoriasi a chiazze disseminate con prevalente componente cheratosica: Studio clinico multicentrico, randomizzato, in doppio cieco, controllato con placebo

Giornale Italiano di Dermatologia e Venereologia

Volumn 136, Issue 1, 2001, Pages 77-83

  Santoianni, P ^a   Di Iorio, S ^a   Giannetti, A ^a   Manfredi, G ^a   Rebora, A ^a   Landi, G ^a   Fiorentino, D ^a   Fileccia, P ^a  

^a IDI Farmaceutici SpA   (Italy)

Author keywords

Betamethasone 17; Drug therapy, combination; Evidence based medicine; Psoriasis, drug therapy; Salicylic acid; Tretinoin; Valerate

Indexed keywords

BETAMETHASONE VALERATE; PLACEBO; RETINOIC ACID; SALICYLIC ACID;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0035027826     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Psoriasis causes as much disability as other major medical diseases
2. Patogenesi della psoriasi
3. Treatment of psoriasis
4. The immunologic and genetic basis of psoriasis
5. Welcome to the "Evidence Based Dermatology". Section in the archives of dermatology
6. Topical all-transretinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect
7. The role of salicylic acid in the treatment of psoriasis
8. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis
9. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis